These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8459640)

  • 21. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
    Iwase H; Morise K; Suga S; Ina K; Masuda T; Ohashi M
    Gan No Rinsho; 1987 Jun; 33(6):729-35. PubMed ID: 3110461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
    Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
    Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy of gastric cancer with oral UFT (a mixture of uracil and fturafur) during the waiting period for surgery.
    Nio Y; Sato Y; Nagami H; Teramoto M; Inoue Y; Yano S; Sumi S; Tamura K; Fukumoto M
    Anticancer Res; 1998; 18(1B):523-30. PubMed ID: 9568172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of advanced gastric cancer remarkably responding to preoperative UFT-E therapy].
    Iwazaki R; Maehiro K; Iijima K; Ota K; Ono Y; Sato K; Okura R; Miwa H; Sato N; Mizobuchi N; Urabe M; Wada R
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):355-9. PubMed ID: 8712830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
    Iwazaki R; Yasutake K; Fukuyama Y; Hasegawa K; Koizumi W; Sasai T; Kurihara M; Kubo Y; Ishikawa K; Hayakawa M
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1179-85. PubMed ID: 8333746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
    Idelevich E; Karminsky N; Dinerman M; Katsenelson RL; Zvi NB; Baruch NB; Biran H; Man S; Shani A
    Acta Oncol; 2007; 46(3):324-9. PubMed ID: 17450467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
    Goto Y; Toyota T; Asaki S; Satoh J; Kikuchi T; Koizumi M; Ohkubo T; Nomura N; Mochizuki F; Taima T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2227-33. PubMed ID: 2500068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
    Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T
    Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
    Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
    Konishi T; Idezuki Y; Watanabe H; Haga S; Ushirokouji Y; Shinohara K; Shibusawa M; Bandai Y; Hiraishi M; Murata N; Yabe K; Yamamura T; Yumoto S; Gunji A; Nishigaki M
    Gan To Kagaku Ryoho; 1998 May; 25(6):887-900. PubMed ID: 9617328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
    Sugimachi K; Okamura T; Furusawa M; Saku M; Noda S; Matsusaka T; Teraoka H; Toda T; Oka N; Inokuchi K
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2953-7. PubMed ID: 3140734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
    Michiwa Y; Earashi M; Kobayashi H; Matsuki N
    J Exp Clin Cancer Res; 2001 Jun; 20(2):297-9. PubMed ID: 11484991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [UFT, UFTM, and UFTM-Dpc treatment of gastric cancer].
    Suga S; Kimura K; Iwase H; Ina K; Takada N; Matsuoka S; Matsuura T; Yamada K; Horiuchi T; Hashizume H
    Gan No Rinsho; 1985 May; 31(6 Suppl):751-6. PubMed ID: 3928942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of unresectable advanced gastric cancer with peritoneal dissemination responding to UET/low-dose CDDP combination chemotherapy].
    Baba M; Higaki N; Nishihara M; Ishida M; Kawasaki H; Sasayama Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2541-4. PubMed ID: 12506479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
    Danno M; Shiroto H; Kunii Y; Ishibiki K; Yamamura Y; Sakamoto Y; Tamura Y; Kunitomo K; Kumashiro R;
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):195-203. PubMed ID: 11242646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.